Multiple Myeloma Research Foundation Announces First Patient Enrolled in Its Horizon Clinical Trials Program to Accelerate Identification of Optimal Treatment Strategies for Multiple Myeloma
December 05, 2024
December 05, 2024
NORWALK, Connecticut, Dec. 5 -- The Multiple Myeloma Research Foundation issued the following news release on Dec. 4, 2024:
* * *
The Horizon Clinical Trials Program uses an adaptive platform designed to test multiple therapies simultaneously to determine the best combination, sequence, and duration of therapy to improve patient outcomes
* * *
The Multiple Myeloma Research Foundation (MMRF(R)) announced today that the first patient had been enr . . .
* * *
The Horizon Clinical Trials Program uses an adaptive platform designed to test multiple therapies simultaneously to determine the best combination, sequence, and duration of therapy to improve patient outcomes
* * *
The Multiple Myeloma Research Foundation (MMRF(R)) announced today that the first patient had been enr . . .